These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8206395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
    Hasler WL, Soudah HC, Owyang C.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1206-11. PubMed ID: 8138933
    [Abstract] [Full Text] [Related]

  • 7. Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs.
    Nakada K, Ikoma A, Suzuki T, Reynolds JC, Campbell WL, Todo S, Starzl TE.
    Am J Surg; 1995 Mar; 169(3):294-9. PubMed ID: 7879829
    [Abstract] [Full Text] [Related]

  • 8. Octreotide reduces perception of rectal electrical stimulation by spinal afferent pathway inhibition.
    Chey WD, Beydoun A, Roberts DJ, Hasler WL, Owyang C.
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G821-6. PubMed ID: 8572212
    [Abstract] [Full Text] [Related]

  • 9. A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention.
    Hasler WL, Soudah HC, Owyang C.
    Gastroenterology; 1993 May; 104(5):1390-7. PubMed ID: 8097733
    [Abstract] [Full Text] [Related]

  • 10. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
    Lecomte T, Cavicchi M, Delchier JC.
    Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347
    [Abstract] [Full Text] [Related]

  • 11. Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome.
    Schwetz I, Naliboff B, Munakata J, Lembo T, Chang L, Matin K, Ohning G, Mayer EA.
    Aliment Pharmacol Ther; 2004 Jan 01; 19(1):123-31. PubMed ID: 14687174
    [Abstract] [Full Text] [Related]

  • 12. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
    Hisanaga T, Shinjo T, Morita T, Nakajima N, Ikenaga M, Tanimizu M, Kizawa Y, Maeno T, Shima Y, Hyodo I.
    Jpn J Clin Oncol; 2010 Aug 01; 40(8):739-45. PubMed ID: 20410056
    [Abstract] [Full Text] [Related]

  • 13. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
    Fiorucci S, Distrutti E, Gerli R, Morelli A.
    Am J Gastroenterol; 1994 Apr 01; 89(4):550-5. PubMed ID: 8147358
    [Abstract] [Full Text] [Related]

  • 14. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C, Läritz M, Meurer M, Endres SP, König A, Schindlbeck N.
    Z Gastroenterol; 1997 Oct 01; 35(10):905-12. PubMed ID: 9432812
    [Abstract] [Full Text] [Related]

  • 15. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J.
    Am J Gastroenterol; 1997 Dec 01; 92(12):2250-6. PubMed ID: 9399764
    [Abstract] [Full Text] [Related]

  • 16. Octreotide acts on anorectal physiology: a dynamic study in healthy subjects.
    Siproudhis L, Bellissant E, Juguet F, Allain H, Bretagne JF, Gosselin M.
    Clin Pharmacol Ther; 1998 Oct 01; 64(4):424-32. PubMed ID: 9797799
    [Abstract] [Full Text] [Related]

  • 17. Small bowel motility disorders.
    Camilleri M.
    Rev Gastroenterol Mex; 1994 Oct 01; 59(2):120-6. PubMed ID: 7991964
    [Abstract] [Full Text] [Related]

  • 18. A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatography.
    Van Dam J, Catalano MF, Ferguson DR, Barnes DS, Zuccaro G, Sivak MV.
    Gastrointest Endosc; 1995 Oct 01; 42(4):321-4. PubMed ID: 8536900
    [Abstract] [Full Text] [Related]

  • 19. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide.
    Lanting PJ, Kruijsen MW, Rasher JJ, van den Hoogen FH, Boerbooms AM, van de Putte LB.
    J Rheumatol; 1993 Dec 01; 20(12):2175. PubMed ID: 8014959
    [No Abstract] [Full Text] [Related]

  • 20. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms.
    Di Lorenzo C, Lucanto C, Flores AF, Idries S, Hyman PE.
    J Pediatr Gastroenterol Nutr; 1998 Nov 01; 27(5):508-12. PubMed ID: 9822313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.